1887
Volume 2022, Issue 3
  • ISSN: 0253-8253
  • EISSN: 2227-0426

Abstract

Background: An extremely rare manifestation of perigraft seroma (PGS), in which a dense, semisolid jelly-like mass had formed around the shunt instead of the standard fluid-like form of the usual seroma, leading to misdiagnosis with other entities, such as tumors around the synthetic arterio-venous shunt (AVS) was presented.

Case Report: A 64-year-old male with multiple myeloma post autologous bone marrow transplant with a renal impairment, presented with a rare form of PGS, which was noticed 2 months after placing a synthetic AVS vascular graft. The mass increased in size, and multiple attempts for excision failed due to recurrence, which led to tumor misdiagnosis. The mass reoccurrence stopped completely only after the radical shunt removal.

Conclusion: This case report revealed a rare form of PGS, in which the seroma was represented as a firm, semisolid jelly-like mass rather than the typical fluid type transudate seroma. Despite its rarity, it was associated with a high recurrence rate because unlike the standard perishunt seroma, this semisolid jelly-like material could neither be aspirated, nor could it be resected en-bloc, leading to shunting dysfunction. Its management included advanced imaging and a high probability of shunt removal or replacement.

Loading

Article metrics loading...

/content/journals/10.5339/qmj.2022.20
2022-06-04
2022-09-29
Loading full text...

Full text loading...

/deliver/fulltext/qmj/2022/3/qmj.2022.20.html?itemId=/content/journals/10.5339/qmj.2022.20&mimeType=html&fmt=ahah

References

  1. Ko PJ, Liu YH, Chu JJ, Lin PJ. Effective treatment for recurrent perigraft seromas of upper arm polytetrafluoroethylene grafts: report of two cases. Chang Gung Med J. 2003; 26:(6):440–443.
    [Google Scholar]
  2. Bissacco D, Domanin M, Del Gobbo A, Gabrielli L. Giant perigraft seroma after axillobifemoral bypass for Leriche syndrome: a case report. Ann Vasc Dis. 2016;:9:252–254. doi: 10.3400/avd.cr.16-00052.
    [Google Scholar]
  3. Ladenheim ED, Lum C, Chadwick N, Agrawal S. High incidence of perigraft seroma formation with semisolid jelly-like-coated polytetrafluoroethylene grafts. Semin Dial. 2012; 25:(6):689–692. doi: 10.1111/j.1525-139X.2012.01085.x.
    [Google Scholar]
  4. Blumenberg RM, Gelfand ML, Dale WA. Perigraft seromas complicating arterial grafts. Surgery. 1985; 97:(2):194–204.
    [Google Scholar]
  5. Allaria PM, Lucatello A, Gandini E, Giangrande A. Relapsing seroma in a uremic patient bearing a PTFE graft as vascular access. J Vasc Access. 2001; 2:(1):28–31. doi: 10.1177/112972980100200106.
    [Google Scholar]
  6. Sladen JG, Mandl MA, Grossman L, Denegri JF. Fibroblast inhibition: a new and treatable cause of prosthetic graft failure. Am J Surg. 1985; 149:(5):587–590. doi: 10.1016/s0002-9610(85)80131–8.
    [Google Scholar]
  7. Ahn SS, Machleder HI, Gupta R, Moore WS. Perigraft seroma: clinical, histologic, and serologic correlates. Am J Surg. 1987; 154:(2):173–178. doi: 10.1016/0002-9610(87)90173-5.
    [Google Scholar]
  8. Dauria DM, Dyk P, Garvin P. Incidence and management of seroma after arteriovenous graft placement. J Am Coll Surg. 2006; 203:(4):506–511. doi: 10.1016/j.jamcollsurg.2006.06.002.
    [Google Scholar]
  9. Kadakol AK, Nypaver TJ, Lin JC, et al. Frequency, risk factors, and management of perigraft seroma after open abdominal aortic aneurysm repair. J Vasc Surg. 2011; 54:(3):637–643. doi: 10.1016/j.jvs.2011.03.258.
    [Google Scholar]
  10. Thoo CH, Bourke BM, May J. Symptomatic sac enlargement and rupture due to seroma after open abdominal aortic aneurysm repair with polytetrafluoroethylene graft: Implications for endovascular repair and endotension. J Vasc Surg. 2004; 40:(6):1089–1094. doi: 10.1016/j.jvs.2004.08.057.
    [Google Scholar]
  11. Bissacco D, Domanin M, Romagnoli S, Gabrielli L. Perigraft seroma after extra-anatomic bypass: case series and review of the literature. Ann Vasc Surg. 2017;:44:451–458. doi: 10.1016/j.avsg.2017.03.201.
    [Google Scholar]
  12. Abe S, Kamikubo Y, Shingu Y, Matsumoto R, Takahira M. Endovascular relining of a dacron graft for refractory perigraft seroma. Gen Thorac Cardiovasc Surg. 2021; 69:(2):340–342. doi: 10.1007/s11748-020-01430-2.
    [Google Scholar]
  13. Reyes Valdivia A, Duque Santos Á, Ruales A, Gordillo Alguacil S, Rodríguez Piñeiro M, Gandarias Zúñiga C. The potential relation between polytetrafluoroethylene grafts after open reconstructions for abdominal aortic aneurysm and perigraft seromas. Ann Vasc Surg. 2021;:70:444–448. doi: 10.1016/j.avsg.2020.06.025.
    [Google Scholar]
  14. Vince DJ, LeBlanc JG, Culham JA. Recurrent perigraft seroma treated by graft replacement with homograft iliac artery. Pediatr Cardiol. 1989;:10:113–114. doi: 10.1007/BF02309925.
    [Google Scholar]
  15. Sobrinho G, Henriques SP. Perigraft seromas complicating prosthetic bridge arteriovenous fistula–solution with autogenous vein interposition. Eur J Vasc Endovasc Surg. 2001;:22:469–471. doi: 10.1053/ejvs.2001.1482.
    [Google Scholar]
  16. Imren Y, Qaradaghi L, Oktar GL, Ereren E, Tumer NB. Saphenous vein wrapping for the treatment of a perigraft seroma: report of a case. Surg Today. 2011;:41:549–551. doi: 10.1007/s00595-009-4302-4.
    [Google Scholar]
  17. Gargiulo NJ 3rd, Veith FJ, Scher LA, Lipsitz EC, Suggs WD, Benros RM. Experience with covered stents for the management of hemodialysis polytetrafluoroethylene graft seromas. J Vasc Surg. 2008;:48:216–217.
    [Google Scholar]
  18. Rhodes VJ. Perigraft seroma: simple solution to a difficult problem. J Vasc Surg. 1986;:3:939. doi: 10.1016/0741-5214(86)90437-4.
    [Google Scholar]
  19. Hiramatsu Y, Atsumi N, Sasaki A, Mitsui T. A successful treatment of serous leakage from a polytetrafluoroethylene Blalock-Taussig shunt with intravenous fibrinogen. J Thorac Cardiovasc Surg. 1999; 117:(6)1230–1231. doi: 10.1016/s0022-5223(99)70274-6.
    [Google Scholar]
  20. Matsuura S, Takayama T, Oyama TG, et al. A radiation-crosslinked gelatin hydrogel that promotes tissue incorporation of an expanded polytetrafluoroethylene vascular graft in rats. Biomolecules. 2021; 11:(8):1105. doi: 10.3390/biom11081105.
    [Google Scholar]
  21. Parrott NR, Scott PD, Freemont AJ, Johnson RW. Angiosarcoma in an arteriovenous fistula following successful renal transplantation–a case report. Transplantation. 1993; 55:(3):676–677.
    [Google Scholar]
  22. Bessis D, Sotto A, Roubert P, Chabrier PE, Mourad G, Guilhou JJ. Endothelin-secreting angiosarcoma occurring at the site of an arteriovenous fistula for haemodialysis in a renal transplant recipient. Br J Dermatol. 1998; 138:(2):361–363. doi: 10.1046/j.1365-2133.1998.02096.x.
    [Google Scholar]
  23. Wehrli BM, Janzen DL, Shokeir O, Masri BA, Byrne SK, O'Connell JX. Epithelioid angiosarcoma arising in a surgically constructed arteriovenous fistula: a rare complication of chronic immunosuppression in the setting of renal transplantation. Am J Surg Pathol. 1998; 22:(9):1154–1159. doi: 10.1097/00000478-199809000-00016.
    [Google Scholar]
  24. Webster P, Wujanto L, Fisher C, et al. Malignancies confined to disused arteriovenous fistulae in renal transplant patients: an important differential diagnosis. Am J Nephrol. 2011; 34:(1):42–48. doi: 10.1159/000328908.
    [Google Scholar]
  25. Farag R, Schulak JA, Abdul-Karim FW, Wasman JK. Angiosarcoma arising in an arteriovenous fistula site in a renal transplant patient: a case report and literature review. Clin Nephrol. 2005; 63:(5):408–412. doi: 10.5414/cnp63408.
    [Google Scholar]
  26. Qureshi YA, Strauss DC, Thway K, Fisher C, Thomas JM. Angiosarcoma developing in a non-functioning arteriovenous fistula post-renal transplant. J Surg Oncol. 2010; 101:(6):520–523. doi: 10.1002/jso.21516.
    [Google Scholar]
  27. Byers RJ, McMahon RF, Freemont AJ, Parrott NR, Newstead CG. Epithelioid angiosarcoma arising in an arteriovenous fistula. Histopathology. 1992; 21:(1):87–89. doi: 10.1111/j.1365-2559.1992.tb00352.x.
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journals/10.5339/qmj.2022.20
Loading
/content/journals/10.5339/qmj.2022.20
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error